Covid-19 & Pharmaceutical manufacturing: the challenges for production quality, safety and continuity
Covid-19 & Pharmaceutical manufacturing: the challenges for production quality, safety and continuity
Tag: FDA
Nitrosamines RA evaluation deadline extended due to coronavirus spreading
European Medicines Regulatory Network agreed to proceed with the extension of the Step 1 (risk evaluation) deadline to October 1st, 2020, due to Covid-19 spreading.
Why MD Cybersecurity is so important
Why MD Cybersecurity is so important by Danilo Maruccia, Executive Consultant & […]
PDA-FDA Joint Regulatory Conference 2019
Washington DC (USA) ● Sept 16th-18th, 2019
FDA temporarily raising tolerance on impurities due to market shortage
FDA has issued setting temporary rules on a probable cancer-causing impurity formerly […]
Olive oil is a medicine according to FDA
Yes it is! Recently the U.S. Food and Drug Administration (FDA) has […]